Industry Veteran Susan Benton Joins the Ocuphire Pharma Board of Directors

Nov 6, 2020

Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP

Nov 5, 2020

Rexahn Pharmaceuticals Announces Expected Effectiveness of Reverse Stock Split and Merger Transaction with Ocuphire Pharma

Nov 5, 2020

Ocuphire Pharma to Host Key Opinion Leader Event on Nyxol® and APX3330

Nov 3, 2020

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma

Nov 2, 2020

Ocuphire to Participate in Upcoming Virtual Healthcare Investor Conferences in September

Sep 9, 2020

Rexahn and Ocuphire Enter into Definitive Merger Agreement

Jun 17, 2020

Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals

Jan 22, 2020

Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol® Eye Drops

Nov 7, 2019

Rexahn to Explore Strategic Alternatives

Sep 24, 2019